CHARLOTTE, N.C.–(BUSINESS WIRE)–EnPro Industries, Inc. (NYSE: NPO), a leading manufacturer of engineered industrial products, today announced it has acquired The Aseptic Group (comprising Aseptic Process Equipment SAS and Aseptic Services SARL), a privately-held company which distributes, designs and manufactures aseptic fluid transfer products for the pharmaceutical and biopharmaceutical industries. The Aseptic Group will become part of EnPro’s Garlock Family of Companies, a leading global supplier of high-performance sealing and fluid handling products to process industries. The business was acquired in a cash transaction.
The Aseptic Group, headquartered in Limonest, France, is a recognized supplier of high purity fluid path components that has been serving some of the world’s largest pharmaceutical companies for over 20 years. The company is at the forefront of developing products and capabilities to support the latest manufacturing techniques currently being adopted to produce next generation biopharmaceutical drugs. The high level of operational excellence, product quality, and strict documentation expected by this emerging industry requires a deep understanding, expertise, and investment compared to traditional pharmaceutical manufacturing.
Mike Faulkner, president of Garlock said, “The Aseptic Group’s focus is highly complementary with Garlock’s strategic market vision. With expert product design knowledge, world-class manufacturing, and supply chain integrity, The Aseptic Group platform is highly leverageable as we continue to build our global capabilities. This addition will allow us to further expand our product offering and deliver value-added solutions to further support our customers in these demanding and highly regulated industries.”
Commenting on the acquisition of The Aseptic Group, Steve Macadam, president and chief executive officer of EnPro Industries said “The acquisition of The Aseptic Group represents our ongoing commitment to invest in the pharmaceutical and biopharmaceutical industries that form a key part of the strategic growth plan for Garlock. In particular, we are highly impressed with the focus that The Aseptic Group places on the biopharmaceutical industry. We are excited to welcome The Aseptic Group employees to EnPro and Garlock, and we look forward to the benefits this business combination will bring to our customers and collective team.”